128800-36-2 Usage
General Description
Benzoic acid, 2-chloro-4,5-difluoro-, methyl ester is a chemical compound with the molecular formula C8H5ClF2O2. It is a methyl ester derivative of 2-chloro-4,5-difluorobenzoic acid, and it is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. Benzoic acid, 2-chloro-4,5-difluoro-, methyl ester has a white crystalline appearance, and it is primarily used as a building block in organic synthesis. It is important to handle this chemical with caution, as it can be harmful if ingested, inhaled, or comes into contact with the skin. Therefore, proper safety measures and protective equipment should be used when handling this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 128800-36-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,8,0 and 0 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 128800-36:
(8*1)+(7*2)+(6*8)+(5*8)+(4*0)+(3*0)+(2*3)+(1*6)=122
122 % 10 = 2
So 128800-36-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H5ClF2O2/c1-13-8(12)4-2-6(10)7(11)3-5(4)9/h2-3H,1H3
128800-36-2Relevant articles and documents
THIADIAZOLE MODULATORS OF S1P AND METHODS OF MAKING AND USING
-
Paragraph 0121, (2017/01/26)
The invention is directed to compounds of the formula: wherein each of the variables are defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance treating an autoimmune disease.
Compounds and methods for F labelled agents
-
, (2008/06/13)
This invention relates to novel compounds suitable for or already radiolabeled with 18F, methods of making such compounds and use of such compounds for diagnostic imaging. Such labeled compounds are characterized by Formula 11, wherein the subs
COMPOUNDS AND METHODS FOR 18F LABELED AGENTS
-
Page/Page column 137, (2010/11/30)
The present invention relates to novel compounds suitable for or already radiolabeled with 18F, methods of making such compounds and use of such compounds for diagnostic imaging. Such labeled compounds are characterized by Formula II, wherein the substituents G, Q, L, Y and U have the meaning as defined in the specification and claims.
